Training workshops designed to share best practices and advice on robust assay design, development and implementation for researchers involved in the drug discovery process.
The Assay Guidance Manual initiative delivers resources on best practices within the early stages of development as well as training focusing on robust, early-stage drug discovery assays.
The BrIDGs program assists researchers in advancing promising therapeutic agents through late-stage pre-clinical development toward an Investigational New Drug (IND) application and clinical testing.
TRND program supports pre-clinical development of therapeutic candidates intended to treat rare or neglected disorders, with the goal of enabling an Investigational New Drug (IND) application.